Inflation Reduction Act: A Double-Edged Sword for Medicare Beneficiaries: The Biden administration’s recent announcement of the first Medicare drug price cuts, mandated by the 2022 Inflation Reduction Act, has dominated headlines. However, another significant impact of this law—substantial premium hikes for some Medicare beneficiaries—has largely been overlooked. The Inflation Reduction Act represents the most sweeping […]
The Centers for Medicare and Medicaid Services (CMS) recently updated guidance on the use of 340B modifiers by Medicare providers and reimbursement providers for drugs Part B biologics and the 340B Drug Enforcement Program. Published participation. The purpose of this rulemaking is to inform all provider types about the newly amended 340B requirements for 2024 […]
The open enrollment period has commenced for individuals obtaining health insurance through the Marketplaces established under the Affordable Care Act (ACA). On November 1, the President expressed optimism about the 2024 registration period, which runs from that day until January 15, 2024. Since last week, both the President and the U.S. Department of Health and […]
The President administration has announced its intention to restrict the sale of “junk” insurance policies, including short-term plans that may not provide adequate coverage for individuals who are in-between jobs and require temporary health care coverage. These policies have been known to deny basic coverage to policyholders. On Friday, President announced a set of fresh […]
The American Hospital Association (AHA) and Better Medicare Alliance (BMA) both support the agency’s effort to improve Medicare Advantage (MA). In an attempt to reform MA, CMS released a proposed rule that aims to streamline prior authorization, promote health equity, and curb deceptive marketing. The Biden administration has shown a commitment to increasing oversight of […]
The bill would allow Medicare to negotiate lower drug prices, particularly for the most expensive that have been on the market for years. In a 51-50 vote with Vice President Kamala Harris as the tie-breaker, the Senate on Saturday passed the Inflation Reduction Act that includes much of the sought-after Democratic priorities on drug negotiations […]